The High Cost of “orphan disease” drugs–Alternative options for purchase of signature pharmaceuticals?

Paying $10,000 a year for a drug dealing with Multiple Sclerosis, a “specialty drug.” U.S. pharmaceuticals tied to the U.S. Congress which refuses to mediate or set prices ON BEHALF of the common, American citizen. Thoughts? Counsel? Thank you for any help.

submitted by /u/jethomme44
[link] [comments]Paying $10,000 a year for a drug dealing with Multiple Sclerosis, a “specialty drug.” U.S. pharmaceuticals tied to the U.S. Congress which refuses to mediate or set prices ON BEHALF of the common, American citizen. Thoughts? Counsel? Thank you for any help. submitted by /u/jethomme44 [link] [comments]Read Morer/HealthInsurance

Leave a Reply

Your email address will not be published.